A personalized approach to the treatment of hydrocephalus associated with medulloblastoma in children
https://doi.org/10.18705/2782-3806-2025-5-1-87-93
EDN: XETWYB
Abstract
To this day, there is no Class I (A) evidence base that could serve as a guideline for the treatment of tumor-associated hydrocephalus in children. Tumors of the posterior cranial fossa (PCF), due to their special interaction with the cerebrospinal fluid pathways, are most often accompanied by the development of hydrocephalus. It is debatable which treatment tactics should be applied correctly: whether to install an external ventricular drainage or a ventriculoperitoneal shunt, whether to perform an endoscopic triventriculostomy, or postpone the procedure of cerebrospinal fluid removal until resection of the tumor. This does not exclude the progression of post-resection hydrocephalus, which occurs in 37 % of cases in the pediatric population.
About the Authors
M. S. NikolaenkoRussian Federation
Nikolaenko Mikhail S., Candidate of Medical Sciences, Neurosurgeon, neurosurgical department for children № 7
Akkuratova str., 2, Saint Petersburg, 197341
K. A. Samochernykh
Russian Federation
Samochernych Konstantin A., Doctor of Medical Sciences professor of the Russian Academy of Sciences, director of the Polenov Neurosurgical Institute – branch Almazov National Medical Research Centre; Head of the Research Center for Personalized Oncology, World-Class Research Centre for Personalized Medicine
Akkuratova str., 2, Saint Petersburg, 197341
N. K. Samochernykh
Russian Federation
Samochernych Nikita K., neurosurgical department for children № 5
Akkuratova str., 2, Saint Petersburg, 197341
A. Yu. Voevodkina
Russian Federation
Voevodkina Alina Yu., Neurosurgeon, Polenov Neurosurgical Institute – branch of Almazov National Medical Research Centre
Akkuratova str., 2, Saint Petersburg, 197341
References
1. Samochernykh NK, Abramov KB, Nikolaenko MS, et al. Treatment of patients with posthemorrhagic hydrocephalus. Rossiiskii Vestnik Perinatologii i Pediatrii=Russian Bulletin of Perinatology and Pediatrics. 2021;66(5):97–104.
2. Marx S, Reinfelder M, Matthes M, et al. Frequency and treatment of hydrocephalus prior to and after posterior fossa tumor surgery in adult patients. Acta Neurochir (Wien). 2018;160(5):1063–1071. DOI:10.1007/s00701-018-3496-x.
3. Won SY, Dubinski D, Behmanesh B, et al. Management of hydrocephalus after resection of posterior fossa lesions in pediatric and adult patients-predictors for development of hydrocephalus. Neurosurg Rev. 2020;43(4):1143–1150. DOI:10.1007/s10143-019-01139-8.
4. Anania P, Battaglini D, Balestrino A, et al. The role of external ventricular drainage for the management of posterior cranial fossa tumours: a systematic review. Neurosurg Rev. 2021;44(3):1243–1253. DOI:10.1007/s10143-020-01325-z.
5. Dewan MC, Lim J, Shannon CN, Wellons JC III. The durability of endoscopic third ventriculostomy and ventriculoperitoneal shunts in children with hydrocephalus following posterior fossa tumor resection: a systematic review and time-to-failure analysis. J Neurosurg Pediatr. 2017;19:578–584. DOI: 10.3171/2017.1.PEDS16536.
6. Marx S, El Damaty A, Manwaring J, et al. Endoscopic Third Ventriculostomy before Posterior Fossa Tumor Surgery in Adult Patients. J Neurol Surg A Cent Eur Neurosurg. 2018;79(2):123–129. DOI:10.1055/s-0037-1608786.
7. Won SY, Gessler F, Dubinski D, et al. A novel grading system for the prediction of the need for cerebrospinal fluid drainage following posterior fossa tumor surgery. J Neurosurg. 2019;132(1):296–305. DOI:10.3171/2018.8.JNS181005.
8. Frisoli F, Kakareka M, Cole KA, et al. Endoscopic third ventriculostomy prior to resection of posterior fossa tumors in children. Childs Nerv Syst. 2019;35(5):789–794. DOI:10.1007/s00381-019-04125-z.
9. Srinivasan HL, Foster MT, van Baarsen K, et al. Does pre-resection endoscopic third ventriculostomy prevent the need for post-resection CSF diversion after pediatric posterior fossa tumor excision? A historical cohort study and review of the literature. J Neurosurg Pediatr. 2020;25(6):615–624. Published 2020 Feb 21. DOI:10.3171/2019.12.PEDS19539.
10. Le Fournier L, Delion M, Esvan M, et al. Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation. Childs Nerv Syst. 2017;33(9):1473–1480. DOI:10.1007/s00381-017-3447-5.
11. Sherrod BA, Iyer RR, Kestle JRW. Endoscopic third ventriculostomy for pediatric tumor-associated hydrocephalus. Neurosurg Focus. 2020;48(1):E5. DOI:10.3171/2019.10.FOCUS19725.
12. Schneider C, Ramaswamy V, Kulkarni AV, et al. Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery. J Neurosurg Pediatr. 2015;15(3):236–242. DOI:10.3171/2014.9.PEDS14280.
13. Abraham AP, Moorthy RK, Jeyaseelan L, Rajshekhar V. Postoperative intraventricular blood: a new modifiable risk factor for early postoperative symptomatic hydrocephalus in children with posterior fossa tumors. Childs Nerv Syst. 2019;35(7):1137–1146. DOI:10.1007/s00381-019-04195-z.
14. Lin CT, Riva-Cambrin JK. Management of posterior fossa tumors and hydrocephalus in children: a review. Childs Nerv Syst. 2015;31(10):1781–1789. DOI:10.1007/s00381-015-2781-8.
15. Tamburrini G, Frassanito P, Bianchi F, et al. Closure of endoscopic third ventriculostomy after surgery for posterior cranial fossa tumor: The “Snow Globe effect”. Br J Neurosurg. 2015;29:386–389. DOI:10.3109/02688697.2014.987214.
16. Dasgupta A, Gupta T, Pungavkar S, et al. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients. Neuro Oncol. 2019;21(1):115–124. DOI:10.1093/neuonc/noy093.
17. Keil VC, Warmuth-Metz M, Reh C, et al. Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype. AJNR Am J Neuroradiol. 2017;38(10):1892–1898. DOI:10.3174/ajnr.A5313.
18. Bateman GA, Fiorentino M. Childhood hydrocephalus secondary to posterior fossa tumor is both an intra- and extraaxial process. J Neurosurg Pediatr. 2016;18(1):21–28. DOI:10.3171/2016.1.PEDS15676.
19. Nishiyama K, Mori H, Tanaka R. Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus. J Neurosurg. 2003;98(5):1027–1031. DOI:10.3171/jns.2003.98.5.1027.
20. Xachatryan VA, Samocherny`x KA, Kim AV, et al. Ventriculosynustransverzostomy in the treatment of decompensated hydrocephalus in children (results of clinical testing of the method). Translyatsionnaya medicina=Translational medicine. 2017;4(1):20–28.
21. Xachatryan VA, Ulitin AYu, Kumirova E`V, et al. Medulloblastoma in children (literature review). Part 2. Complex treatment. Nejroxirurgiya i nevrologiya detskogo vozrasta=Neurosurgery and neurology of childhood. 2014;2(40):68–80.
22. Kim AV, Samocherny`x KA. Brain tumors in children of the first two years of life. Nejroxirurgiya i nevrologiya detskogo vozrasta=Neurosurgery and neurology of childhood. 2010;3–4(25–26):82–94.
23. Xachatryan VA, Ulitin AYu, Samocherny`x KA, et al. Medulloblastoma in children (literature review). Part I. Epidemiology. Pathomorphology. Diagnostics. Nejroxirurgiya i nevrologiya detskogo vozrasta=Neurosurgery and neurology of childhood. 2013;4(38):59–70.
Review
For citations:
Nikolaenko M.S., Samochernykh K.A., Samochernykh N.K., Voevodkina A.Yu. A personalized approach to the treatment of hydrocephalus associated with medulloblastoma in children. Russian Journal for Personalized Medicine. 2025;5(1):87-93. (In Russ.) https://doi.org/10.18705/2782-3806-2025-5-1-87-93. EDN: XETWYB